Form D · Biotechnology
Harvard Apparatus Regenerative Technology, Inc.
Holliston, MA · CIK 0001563665
Offering snapshot reported Sep 14, 2026 · SEC filing
- Reported sold
- $2.84M Offering amount: $3M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2026 | Initial | $2,838,911 | No comparison | 6 | SEC filing |
| Jan 6, 2026 | Initial | $700,000 | No comparison | 2 | SEC filing |
| Jul 14, 2025 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Aug 6, 2024 | Initial | $1,482,100 | No comparison | 4 | SEC filing |
| Apr 14, 2023 | Initial | $6,005,800 | No comparison | 14 | SEC filing |
| Jun 8, 2022 | Initial | $5,060,240 | No comparison | 25 | SEC filing |
| Sep 10, 2021 | Amendment | $2,600,000 | $2,000,000vs Jun 23, 2021 | 2 | SEC filing |
| Jun 23, 2021 | Initial | $600,000 | No comparison | 2 | SEC filing |
| Aug 31, 2020 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Apr 23, 2020 | Initial | $2,177,502 | No comparison | 4 | SEC filing |
| Sep 19, 2019 | Initial | $1,277,143 | No comparison | 7 | SEC filing |
| Jul 11, 2018 | Initial | $900,000 | No comparison | 1 | SEC filing |
| Jun 21, 2018 | Initial | $3,600,000 | No comparison | 2 | SEC filing |
| Feb 27, 2018 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Feb 2, 2018 | Initial | $4,244,000 | No comparison | 5 | SEC filing |
| Jun 1, 2016 | Initial | $5,000,001 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-597327
Source: Form D, filed Sep 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Canepa | Director |
| Peter Chakoutis | Executive |
| Jing Chen | Director |
| Matthew Dallas | Director |
| Joseph Damasio | Executive |
| William Fodor | Executive |
| David Green | Director |
| Junli He | Director, Executive |
| Shunfu Hu | Executive |
| John Kennedy | Director |
| Ting Li | Director |
| James Mc Gorry | Director, Executive |
| Blaine Mc Kee | Director |
| Thomas Mc Naughton | Executive |
| Ronald Packard | Director |
| Thomas Robinson | Director |
| Herman Sanchez | Director |
| La Francesca Saverio | Executive |
| James Shmerling | Director |
| Jeffrey Young | Director |
| Hong Yu | Executive |
| Wei Zhang | Director |
| Mao Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
84 October Hill Road Suite 11
Holliston, MA, 01746
Phone: 774-233-7300
Holliston, MA, 01746
Phone: 774-233-7300